Investors may find better financial performance in Viemed Healthcare Inc (VMD)

Kevin Freeman

Viemed Healthcare Inc [VMD] stock is trading at $7.43, down -0.93%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VMD shares have gain 1.92% over the last week, with a monthly amount glided 8.15%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Viemed Healthcare Inc [NASDAQ: VMD] stock has seen the most recent analyst activity on March 05, 2021, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $13.

Viemed Healthcare Inc [VMD] stock has fluctuated between $5.93 and $8.61 over the past year. Viemed Healthcare Inc [NASDAQ: VMD] shares were valued at $7.43 at the most recent close of the market.

Analyzing the VMD fundamentals

Viemed Healthcare Inc [NASDAQ:VMD] reported sales of 254.79M for the trailing twelve months, which represents a growth of 23.98%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.11 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.37 points at the first support level, and at 7.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.51, and for the 2nd resistance point, it is at 7.58.

Ratios To Look Out For

For context, Viemed Healthcare Inc’s Current Ratio is 1.13. In addition, the Quick Ratio stands at 1.01 and the Cash Ratio stands at 0.54. Considering the valuation of this stock, the price to sales ratio is 1.11, the price to book ratio is 2.11 and price to earnings (TTM) ratio is 22.47.

Transactions by insiders

Recent insider trading involved Cambre Jerome, Vice President of Sales, that happened on Aug 13 ’25 when 4880.0 shares were sold. President, Moore Michael completed a deal on Aug 12 ’25 to sell 50090.0 shares. Meanwhile, President Moore Michael sold 0.18 million shares on Jun 30 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.